NCT06306326 3D Facial Scanning for Evaluating Autologous Fat Grafting in Craniofacial Deformities
| NCT ID | NCT06306326 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University |
| Condition | Adipocytes |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-04-27 |
| Primary Completion | 2028-05-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-04-27 with a primary completion date of 2028-05-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Treatment of craniofacial deformities is a significant topic in oral and maxillofacial surgery, and autologous fat grafting has become one of the main methods for treating facial concave deformities. However, the instability of its treatment effect has always been a bottleneck in this field, mainly due to the uncertain absorption rate of transplanted fat. This project aims to use advanced the 3dMD face system (3dMD) (3dMD Inc, Atlanta, Ga) technology to precisely measure the facial volume changes before and after autologous fat grafting to address this issue. By performing autologous fat grafting surgery on 100 patients with craniofacial deformities that meet the research criteria, 3dMD technology will be used for facial three-dimensional scanning preoperatively, immediately postoperatively, and at six months postoperatively to obtain facial volume data. Then, through precise data analysis, we will calculate the fat absorption rate and study the effects of individual factors on treatment outcomes through correlation regression analysis.
Eligibility Criteria
Inclusion Criteria: * Facial soft tissue volume deficiency deformity caused by congenital/acquired factors, meeting the indications for autologous fat grafting surgery. * Good physical health, without severe systemic diseases or infectious diseases. * Not pregnant and without plans for pregnancy. * Signed informed consent form. Exclusion Criteria: * Contraindications to general anesthesia. * Patient refusal to participate in this study. * Significant contour changes in non-filled facial areas during follow-up period leading to inability to register data.
Contact & Investigator
Xi Gong, Dr
STUDY DIRECTOR
Peking University School and Hospital of Stomatology
Frequently Asked Questions
Who can join the NCT06306326 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 80 Years, studying Adipocytes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06306326 currently recruiting?
Yes, NCT06306326 is actively recruiting participants. Contact the research team at 15201304426@163.com for enrollment information.
Where is the NCT06306326 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06306326 clinical trial?
NCT06306326 is sponsored by Peking University. The principal investigator is Xi Gong, Dr at Peking University School and Hospital of Stomatology. The trial plans to enroll 100 participants.